When a migraine begins, reaching for something cold is almost instinctive.

A cold compress across the forehead. An ice pack wrapped around the neck. A cooling cap pulled over the scalp.

For many people, cold simply feels good during a migraine.

Research suggests there may be more behind that response than comfort alone. Controlled cooling can influence sensory nerves, blood vessels and pain signalling around the head and neck, potentially reducing the intensity of migraine pain for some users.

But this is also an area where the technology is often oversimplified.

Cryotherapy does not “switch off” a migraine, and colder does not automatically mean better. The strongest evidence currently relates to targeted head and neck cooling rather than extreme whole-body cryotherapy.

Understanding that difference is essential for both users and companies developing cold-therapy technology.

What is migraine cryotherapy?

Cryotherapy simply means using cold for a therapeutic purpose.

In migraine research, that usually means applying controlled cooling to a specific area of the head or neck.

This can include:

• Cooling caps
• Gel packs
• Forehead compresses
• Neck wraps
• Controlled scalp-cooling systems
• Intranasal cooling technologies

These approaches are very different from whole-body cryotherapy, where the entire body is exposed to extremely cold air inside a cryotherapy chamber.

The existing migraine evidence is primarily focused on localized cooling.

There is currently insufficient evidence to conclude that whole-body cryotherapy can reliably prevent or treat migraine attacks.

Why does cold feel good during a migraine?

Migraine is a neurological disorder.

It involves altered activity within the brain and trigeminal nervous system, together with changes in signalling molecules such as calcitonin gene-related peptide, or CGRP.

This is important because migraine is sometimes explained simply as a problem of widened blood vessels.

The biology is considerably more complex.

Cooling may influence migraine pain through several overlapping mechanisms.

Reduced sensory nerve activity

Cold can temporarily decrease the speed and sensitivity of sensory nerve signalling.

This creates the familiar numbing effect we experience when applying an ice pack to a painful area.

Around the forehead, temples, scalp or neck, this may reduce the intensity of pain signals reaching the brain.

Changes in superficial blood flow

Cooling causes superficial blood vessels to narrow.

This process, known as vasoconstriction, reduces blood flow close to the skin and changes the local tissue environment.

It may contribute to symptom relief, although migraine should not be treated as a purely vascular condition.

Modulation of trigeminal pain signalling

The trigeminal system is heavily involved in migraine pain.

Cold applied around areas supplied by trigeminal nerves may alter how these sensory signals are processed.

The exact mechanism is still being investigated, but this provides one potential explanation for why forehead and temple cooling can feel particularly effective during an attack.

A competing sensory signal

Cold also creates a strong sensory input of its own.

When the nervous system is receiving an intense cold sensation at the same time as pain signals, the way those signals are perceived may temporarily change.

In practical terms, the cold can partially compete with the migraine sensation.

What does the research show?

The current research is encouraging, but still relatively limited.

A 2023 systematic review and meta-analysis examining cold interventions for migraine found evidence that cooling can help reduce migraine symptoms.

However, the studies included different cooling methods, treatment durations and patient groups, making it difficult to define one universally effective protocol.

Earlier clinical studies also reported positive results.

A randomized controlled trial involving targeted neck cooling found a significant reduction in migraine pain among participants using the cooling treatment.

Other pilot studies using cold caps and targeted cooling have reported similar short-term improvements.

The overall picture is therefore reasonably consistent:

Targeted cooling appears capable of reducing migraine pain for some people.

What the research does not yet show is that one cooling technology, temperature or treatment duration works best for everyone.

Timing may be important

Cold therapy appears to be most useful during an active migraine attack.

In particular, applying cooling early may provide more relief than waiting until the pain has become severe.

This makes sense from a practical perspective.

Once an attack has progressed, multiple neurological and sensory processes may already be strongly activated.

Cooling cannot necessarily reverse the full migraine cascade.

Instead, it may help reduce the intensity of the pain and make the attack easier to manage.

This means cryotherapy is better viewed as an acute supportive intervention than as a proven long-term migraine-prevention strategy.

Where should the cold be applied?

There is no single treatment location that works for everyone.

Common areas include:

• Forehead
• Temples
• Scalp
• Back of the head
• Upper neck

Some people experience pain primarily around one eye or temple. Others feel strong discomfort around the back of the head or neck.

The most useful cooling location may therefore depend partly on where the individual experiences pain and sensitivity.

Research has also investigated neck cooling because of the relationship between cervical structures, sensory input and migraine discomfort.

However, neck tension itself should not automatically be treated as the cause of the migraine.

It may be part of the attack rather than its underlying origin.

What about intranasal cooling?

An interesting development in migraine cryotherapy is controlled intranasal cooling.

Instead of placing cold against the skin, these systems deliver cooled or dehumidified air through the nasal cavity.

Pilot research has investigated whether this can influence pain pathways associated with migraine.

Some studies have reported promising results, but the technology remains less established than simple external cooling methods.

It illustrates an important trend within therapeutic cooling: increasingly precise systems are being developed to target specific anatomical regions rather than exposing the entire body to extreme cold.

Does colder mean more effective?

No.

This is one of the most important principles in cold therapy.

A stronger cold sensation does not automatically produce a stronger therapeutic effect.

Extreme temperatures can increase the risk of:

• Skin damage
• Cold burns
• Numbness
• Nerve injury
• Excessive discomfort

The objective should therefore be controlled cooling, not maximum cooling.

The same principle applies to treatment duration.

Keeping an extremely cold pack against the skin for longer does not guarantee greater migraine relief.

Effective technology needs to control the exposure carefully enough to create a meaningful cooling effect without unnecessarily increasing risk.

Cooling caps and wearable migraine devices

Wearable cooling products are particularly interesting because they can deliver cold across a larger and more consistent area than a handheld ice pack.

A cooling cap may target the forehead, temples and scalp simultaneously while allowing the user to rest in a dark environment.

More advanced systems could potentially control:

• Treatment temperature
• Exposure duration
• Cooling distribution
• Target location
• Treatment programs

This is where product design becomes important.

Migraine sufferers are often extremely sensitive to pressure, sound, light and movement during an attack.

A technically effective cooling system that is heavy, noisy or uncomfortable may be difficult to tolerate.

For product developers, therapeutic performance therefore needs to be considered together with usability.

Does cryotherapy help with every migraine symptom?

Not necessarily.

Migraine attacks can involve much more than headache.

Symptoms may include:

• Nausea
• Light sensitivity
• Sound sensitivity
• Visual aura
• Dizziness
• Cognitive difficulties or “brain fog”
• Neck discomfort
• Fatigue

Cooling appears most directly relevant to pain relief.

It may make the headache component more manageable without significantly affecting every other migraine symptom.

This is another reason not to position cryotherapy as a complete migraine treatment.

It addresses one part of a much more complex neurological condition.

Cryotherapy and medication

Cold therapy should not be treated as a replacement for prescribed migraine medication.

Instead, it may be used alongside established strategies such as:

• Resting in a quiet, dark room
• Hydration
• Prescribed acute migraine medication
• Reducing sensory stimulation
• Relaxation techniques

Some research suggests that combining cooling with relaxation may provide additional improvements in pain and migraine-related disability.

The objective is not necessarily to replace medication.

For some people, cooling may simply provide another non-invasive tool that makes an attack easier to tolerate.

What about whole-body cryotherapy?

Whole-body cryotherapy is increasingly used across sports recovery and wellness.

But the evidence should not be transferred automatically from one application to another.

Whole-body cryotherapy exposes a person to extremely cold air for a short period, while migraine cooling studies generally focus directly on the head or neck.

These treatments produce very different physiological conditions.

At present, there is not enough clinical evidence to say that whole-body cryotherapy reliably treats or prevents migraines.

For migraine-focused product development, targeted cooling currently has a stronger scientific basis.

Who should be careful with cold therapy?

Local cooling is generally straightforward when used appropriately, but cold exposure is not completely risk-free.

Care is particularly important for people with:

• Reduced skin sensation
• Circulation disorders
• Raynaud's phenomenon
• Cold hypersensitivity
• Previous cold injury
• Neurological conditions affecting temperature sensation

Extremely cold products should not be applied directly to unprotected skin for prolonged periods.

Treatment should also be stopped if cooling causes persistent numbness, severe pain, unusual skin colour changes or other unexpected symptoms.

When a headache needs medical attention

Not every severe headache is a migraine.

Urgent medical assessment is important when a headache is:

• Sudden and extremely severe
• The worst headache someone has experienced
• Associated with weakness or paralysis
• Accompanied by difficulty speaking
• Associated with confusion or seizures
• Combined with persistent vision loss
• Accompanied by fever and neck stiffness
• Experienced after a significant head injury

A substantial change in a person's normal headache pattern should also be medically evaluated.

Cold therapy should never delay the assessment of a potentially serious neurological problem.

What this means for cold-therapy product development

The migraine research demonstrates an important principle for therapeutic device development.

The treatment needs to match the biology.

A generalized promise that “cold reduces inflammation” is not enough.

A migraine-specific system needs to consider where cooling is delivered, how quickly temperature changes, how evenly it is distributed, how long exposure lasts and whether the device remains comfortable during an attack.

This is particularly important because migraine users can be highly sensitive to pressure and external stimulation.

The most credible devices will therefore not focus on delivering the coldest possible treatment.

They will focus on controlled, repeatable and comfortable cooling.

Conclusion

Cold therapy can help reduce migraine pain for some people.

The strongest evidence currently supports targeted cooling of the head and neck, particularly when used during the early stages of an attack. Cooling may reduce sensory nerve activity, alter superficial blood flow and influence the way pain signals are processed.

But it is not a cure.

Migraine is a complex neurological condition, and cryotherapy does not address every symptom or underlying mechanism.

The opportunity lies in using cold precisely.

For users, that means treating cryotherapy as a supportive tool alongside established migraine care.

For product developers, it means designing systems around controlled temperature, treatment location, exposure time and comfort rather than simply making the treatment colder.

At Light Tree Technology, we develop advanced heating and cooling technologies for beauty, wellness, recovery and medical applications. By combining product development, engineering, regulatory expertise and scalable manufacturing, we help brands turn emerging treatment concepts into controlled, market-ready devices.

Looking to develop a targeted cooling device?

Build the treatment experience around controlled delivery, real-world usability and the intended application from the start.

Start your project with Light Tree Technology.

References

1. Hsu YW, et al. Cold intervention for relieving migraine symptoms: A systematic review and meta-analysis. Journal of Clinical Nursing. 2023.
2. Sprouse-Blum AS, Gabriel AK, Brown JP, Yee MH. Randomized controlled trial: Targeted neck cooling in the treatment of the migraine patient. Hawaii Journal of Medicine & Public Health. 2013;72(7):237–241.
3. Ucler S, Coskun O, Inan LE, Kanatli Y. Cold therapy in migraine patients: Open-label, non-controlled, pilot study. Evidence-Based Complementary and Alternative Medicine. 2006;3(4):489–493.
4. Vanderpol J, Bishop B, Matharu M, Glencorse M. Therapeutic effect of intranasal evaporative cooling in patients with migraine: A pilot study. Journal of Headache and Pain. 2015;16:5.
5. Shah R, et al. Trans-nasal high-flow dehumidified air in acute migraine headaches: A randomized controlled trial. Cephalalgia. 2021.
6. Kisa EP, et al. Effectiveness of cold application combined with progressive muscle relaxation in patients with migraine without aura. 2025.
7. Garcia C, et al. Use of cryotherapy for managing chronic pain: An evidence-based review. 2021.
8. Robblee J, Starling AJ. Diagnosis and acute management of migraine. Canadian Medical Association Journal. 2023.

‍